Impact of Cytomegalovirus in Organ Transplant Recipients in the Era of Antiviral Prophylaxis

Abstract

Late CMV disease is an important clinical problem in liver transplant recipients who receive antiviral prophylaxis, and is strongly and independently associated with mortality. Strategies to prevent late CMV disease are warranted.